These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 24178970)
1. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970 [TBL] [Abstract][Full Text] [Related]
2. Association of C4d deposition with clinical outcomes in IgA nephropathy. Espinosa M; Ortega R; Sánchez M; Segarra A; Salcedo MT; González F; Camacho R; Valdivia MA; Cabrera R; López K; Pinedo F; Gutierrez E; Valera A; Leon M; Cobo MA; Rodriguez R; Ballarín J; Arce Y; García B; Muñoz MD; Praga M; Clin J Am Soc Nephrol; 2014 May; 9(5):897-904. PubMed ID: 24578331 [TBL] [Abstract][Full Text] [Related]
3. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study. Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399 [TBL] [Abstract][Full Text] [Related]
4. The MEST score provides earlier risk prediction in lgA nephropathy. Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ; Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049 [TBL] [Abstract][Full Text] [Related]
5. The use of the Oxford classification of IgA nephropathy to predict renal survival. Alamartine E; Sauron C; Laurent B; Sury A; Seffert A; Mariat C Clin J Am Soc Nephrol; 2011 Oct; 6(10):2384-8. PubMed ID: 21885791 [TBL] [Abstract][Full Text] [Related]
6. A validation study of crescents in predicting ESRD in patients with IgA nephropathy. Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226 [TBL] [Abstract][Full Text] [Related]
7. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy. Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Nagata M; Tsuchimoto A; Hirakata H; Kitazono T; Tsuruya K Clin Exp Nephrol; 2016 Oct; 20(5):689-698. PubMed ID: 26564155 [TBL] [Abstract][Full Text] [Related]
8. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy. Chen T; Li X; Li Y; Xia E; Qin Y; Liang S; Xu F; Liang D; Zeng C; Liu Z Am J Kidney Dis; 2019 Sep; 74(3):300-309. PubMed ID: 31031086 [TBL] [Abstract][Full Text] [Related]
9. Validation of the Oxford classification of IgA nephropathy. Herzenberg AM; Fogo AB; Reich HN; Troyanov S; Bavbek N; Massat AE; Hunley TE; Hladunewich MA; Julian BA; Fervenza FC; Cattran DC Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062 [TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study. Tian S; Yang X; Luo J; Guo H Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045 [TBL] [Abstract][Full Text] [Related]
11. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Edström Halling S; Söderberg MP; Berg UB Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154 [TBL] [Abstract][Full Text] [Related]
12. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy. Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518 [TBL] [Abstract][Full Text] [Related]
13. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy. Zhang J; Wang C; Tang Y; Peng H; Ye ZC; Li CC; Lou TQ Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy. Tanaka S; Ninomiya T; Masutani K; Nagata M; Tsuchimoto A; Tsuruya K; Kitazono T Clin Exp Nephrol; 2015 Dec; 19(6):1062-70. PubMed ID: 25700934 [TBL] [Abstract][Full Text] [Related]
15. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients. Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434 [TBL] [Abstract][Full Text] [Related]
16. Clinical implication of crescentic lesions in immunoglobulin A nephropathy. Lee MJ; Kim SJ; Oh HJ; Ko KI; Koo HM; Kim CH; Doh FM; Yoo TH; Kang SW; Choi KH; Lim BJ; Jeong HJ; Han SH Nephrol Dial Transplant; 2014 Feb; 29(2):356-64. PubMed ID: 24081867 [TBL] [Abstract][Full Text] [Related]
17. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy. Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666 [TBL] [Abstract][Full Text] [Related]
18. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L; Cai K; Wang K; Luo Q J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240 [TBL] [Abstract][Full Text] [Related]
19. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Walsh M; Sar A; Lee D; Yilmaz S; Benediktsson H; Manns B; Hemmelgarn B Clin J Am Soc Nephrol; 2010 Mar; 5(3):425-30. PubMed ID: 20089495 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study. Jebali H; Ghabi H; Mami I; Kaab BB; Fatma LB; Smaoui W; Haouet S; Mahjouba HB; Hassan M; Hmida FB; Raies L; Zouaghi MK Saudi J Kidney Dis Transpl; 2020; 31(6):1366-1375. PubMed ID: 33565449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]